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Abstract: 
In June 2018, MBRRACE-UK published a Perinatal Mortality Surveillance Report that 
outlined that the stillbirth rate for twins has nearly halved, since 2014, whilst the stillbirth rate 
for singleton pregnancies remained static.  There was a statistically significant reduction in 
the rate of stillbirth in twins over this period from 11.07 (95%CI, 9.78 – 12.47) to 6.16 
(95%CI, 5.20 – 7.24) per 1000 total births. This commentary discusses these observations, 
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the effects of twin chorionicity and discusses the potential obstetric and neonatal 
interventions as well as public health improvements that may have influenced these finding. 
 
KEY WORDS: Twins, stillbirth, neonatal death, pregnancy, healthcare improvements. 
 
Stillbirth and neonatal death are devastating perinatal outcomes whose causes are 
multifaceted, complex and incompletely understood. Since 2013, MBRRACE-UK has been 
appointed by the Healthcare Quality Improvement Partnership to conduct the national 
programme of surveillance and investigation into the causes of maternal deaths, stillbirths 
and infant deaths. The Perinatal Mortality Surveillance Report for Births in 2016 was 
published in June 2018. One of the headline findings in this report was that the stillbirth rate 
for twins has nearly halved, since 2014, whilst the stillbirth rate for singleton pregnancies 
remained static.  There was a statistically significant reduction in the rate of stillbirth in twins 
over this period from 11.07 (95%CI, 9.78 – 12.47) to 6.16 (95%CI, 5.20 – 7.24) per 1000 
total births (Figure 1, blue histogram).  In addition, there was a more modest fall in neonatal 
mortality for twin pregnancies from 7.81 (95%CI, 6.73 – 9.01) to 5.34 (95% CI, 4.47 – 6.36) 
per 1000 live births1. These data were validated against routine data collected for all UK 
countries. There were no methodological changes over the years studied.  There was 
considerable stakeholder and media interest in these findings and professional reflection on 
these observations2. 
The publication of the national statistics for perinatal loss is arguably one of the most 
important publications in obstetric, midwifery and neonatal medicine.  Data on twin loss rates 
are available in very few countries and therefore publication of the UK data has international 
applicability and interest. The drive and ability to make improvements in perinatal care 
requires critical appraisal and assessment of these reported findings, along with an 
acknowledgement of any limitations of the report and the concurrent standard of national 
perinatal care.  To these ends, this commentary aims to consider the possible reasons 
underlying this significant and indeed impressive presented fall in stillbirth and neonatal 
death rates in twin pregnancies. Could it, at least in part, be a consequence of chance, 
statistical variability, data acquisition or  does it document a true success of developments in 
obstetric and neonatal care in the UK? 
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It is good scientific practice and wise to be questioning and cautious about the 
validity of relatively short-term trends in clinical outcomes.  Further review of the MBRRACE-
UK data for stillbirth and neonatal death through the total four year period suggests an 
improvement and fall in stillbirth rates in twin pregnancies but these data are not as 
impressive as by focusing upon the last triennia. Indeed, there is a variance in these data 
with 2014 demonstrating a relatively high stillbirth rate and 2016 a relatively low rate.  
Stillbirth (and indeed neonatal loss) rates may be better reported as a “rolling average” (as 
previously reporting in the Scottish datasets) as the MBRRACE-UK dataset expands. 
Examination of the more long-term period by examination of the CEMACH/CMACE (2000-
2009) and Scottish Perinatal Mortality dataset (2007-2012) alongside the current 
MBRRACE-UK data does demonstrate a steady trend in reduction of documented stillbirth 
rate in twins since 2003 (Figure 1). 
 It is widely acknowledged that twins are at higher perinatal risk of in-utero and 
neonatal death than singletons, due to increased rates of congenital malformations, preterm 
birth and fetal growth restriction, as well as specific morbid complications of monochorionic 
twins3,4,5,6. Their close fetal surveillance of twins is warrented7. Monochorionicity has a 
negative influence on gestational age-specific mortality compared to dichorionic twins8,9 as a 
consequence of the complications arising from the conjoining of the fetal circulations within a 
single shared placenta. These complications of twin to twin transfusion syndrome (TTTS), 
selective growth restriction (sGR) and twin anaemia polycythaemia sequence (TAPS) are 
associated with high risks of single or double fetal demise9,10.   Although the death of any 
fetus is a tragedy, a single twin death in a monochorionic pregnancy is a particularly adverse 
event as it may be associated with high rates of subsequent co-twin demise and a greater 
than 24% risk of pathologic neurologic sequelae in a co-twin survivor10.  Monochorionicity is 
also further associated with adverse neonatal outcomes, with an increased incidence of 
preterm birth, low birthweight, more complicated morbidity and often a prolonged stay in the 
neonatal intensive care unit11,12.   
 Accuracy of stillbirth rates in monochorionic twins may be affected by a number of 
confounding factors. The morbid conditions associated with monochorionicity may be 
diagnosed before 24 weeks of gestation and potentially associated with fetal loss at the 
threshold of viability and may be variably classified as late fetal losses, stillbirths or neonatal 
deaths depending upon the clinical judgement as to the timing of demise. Although 
MBRRACE-UK collect fetal loss rates between 22-24 weeks, in the document published1 
only stillbirths (deaths >24 weeks) and neonatal deaths are reported. Thus our ability to 
critique the fetal loss rates for potential classification errors is presently limited.  In addition, 
pregnancy losses (double) in twins under 22 weeks gestation are not captured in our 
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national surveillance data and represent a ‘hidden’ mortality.  A rise in “hidden mortality” will 
have a positive effect to reduce stillbirth rates by potentially removing the most complicated 
monochorionic twin pregnancies from the surveyed population. With this consideration, it is 
certainly possible that increased obstetric surveillance of monochorionic twins has led to 
earlier identification, intervention by fetal therapy and earlier fetal losses associated with 
pathologies such as TTTS and sGR.   
 Although the recently published official MBRRACE report did not breakdown and 
report the twin data by chorionicity, these data are routinely collected.  Due to its importance 
we requested and were granted access to these data.  In the four years (2013-2016), there 
were a total of 817 stillbirths (in-utero deaths >24 weeks) complicating twin pregnancies. Of 
these, 420 stillbirths were classified as monochorionic (51.4%), 331 were classified as 
dichorionic (40.5%) and in 66, unknown chorionicity (8.4%).  From 2013 (21 cases; 10.1%) 
through to 2016 (3 cases; 2%) there was a significant reduction in the number of twin 
pregnancies unclassified by chorionicity with monochorionic twins forming the largest group 
of twin stillbirths by 2014-2016. A similar finding was noted in the neonatal death data.   
 To allow the calculation of loss rates, we required dominator data; the number of all 
live and stillbirths.  Although, the total denominator data from twins is known, subdivision on 
the basis of chorionicity was not possible from these national statistics1.  To calculate 
stillbirth rates on the basis of chorionicity we therefore made the assumption, 20% of the twin 
pregnancies were monochorionic and 80% were dichorionic13,14. The crude data for stillbirth 
over the four years 2013-2016 are shown in Figure 2 and the derived stillbirth rate (per 1000 
total births) in twins by chorionicity compared to the singleton stillbirth rates is represented in 
Figure 3.  There appears to be a reduction in the stillbirth rate in dichorionic twins between 
the beginning (2013) and the end (2016) of the EMBRRACE-UK reported dataset.  The 
stillbirth rates in monochorionic twins is significantly higher than in dichorionic twins or 
singletons (up to five fold increase), but also appear to show a reduction in rate over the 
studied period.    The census data for the EMBRRACE-UK 2018 dataset has not been 
analysed for further clinical information on the twin pregnancies and in particular there was 
no extracted information as to the proportion of monochorionic twins complicated by adverse 
events associated with placental vascular conjoining (i.e. TTTS, sGR or TAPS), rates of fetal 
therapy or the relative rates of preterm birth by chorionicity.  However, this will form the basis 
of a MBRRACE working group studying the 2017 dataset (see below). 
With the knowledge that there appears to have been a steady reduction in perinatal 
mortality of twin pregnancies, we are in a position to consider and speculate upon a number 
of potential key effectors. In 2005, the Royal College of Obstetricians and Gynaecologists 
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(RCOG) recognised and evaluated international awareness that twin and triplet pregnancies 
had specific risks with increased perinatal mortality and morbidity.  A International Scientific 
Study Group was commissioned to bring experts from around the world to discuss evidence 
based best practice15.  The consensus statement from this meeting, built upon other 
international declarations, recognising the specific twin-related obstetric problems compared 
to singleton pregnancy and the need to stratify antenatal care based upon chorionicity16.  In 
the UK, this led to the production of professional quality standards with the RCOG publishing  
‘Green top’ Guidance on the management of monochorionic twin pregnancies (first 
published in 2008 and revised in in 2016)17,18 and then the National Institute for Health and 
Care (NICE) document outlining a template for antenatal care for twin and triplet 
pregnancies, in 201119,20. For the first time, these evidence-based documents outlined 
recommended clinical care and obstetric surveillance in twin and triplet pregnancies.  For 
twins (as well as the rarer triplet pregnancy) there was a focus on the designation of clinical 
chorionicity based upon first trimester ultrasound.  This chorionicity- based program of 
antenatal care, is encapsulated in a guideline recommending a regimen of routine serial 
ultrasound examinations monitoring these pregnancies for chromosomal abnormalities, fetal 
structural anomalies and fetal growth restriction.  The recommended frequency of ultrasound 
scan examinations was higher (at 2 weekly intervals from 16 weeks) in monochorionic twins 
to monitor for twin to twin transfusion syndrome and high rates of sGR19,20.  In addition, it 
recommended that to minimise perinatal deaths in uncomplicated dichorionic twin 
pregnancies, delivery should be considered at 37 weeks’ gestation; in monochorionic 
pregnancies delivery should be considered at 36 weeks. Perhaps though, the most novel 
recommendation of this guideline was that clinical care for women with twin and triplet 
pregnancies should be provided by “a core team of named specialist obstetricians, specialist 
midwives and ultrasonographers, all of whom have experience and knowledge of managing 
twin and triplet pregnancies”21,22. This change focused the care of these high-risk 
pregnancies in the hands of healthcare professionals best placed to implement adequate 
monitoring for maternal and fetal adverse disease processes, allowing the recognition of 
complications earlier so that timely treatment can be offered in appropriate specialist 
centres.  Serial ultrasound scans have allowed better identification and understanding of 
management possibilities in twin pregnancies complicated by selective growth restriction and 
chorionicity-specific management differences in these potentially morbid pregnancies19, 21.   
It is likely that this organisational change is, at least in part, responsible for the 
observed reduction in perinatal and neonatal mortality reported between 2014 – 2016 (and 
perhaps from even earlier) (Figure 1).  From the publication of the RCOG Consensus 
statement in 2006 and then the NICE Guidelines in 2011, it would probably take at least two 
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years for hospital Trusts in the NHS to engage with the recommendations by establishing 
multidisciplinary teams, multiple pregnancy services and an infrastructure to deliver care.  It 
should also be recognised that during this period, parent/patient education regarding the 
expected quality of antenatal care has improved and this has been in no small part because 
of active and educational work performed by the Twins And Multiple Births Association 
(TAMBA) and the Multiple Births Foundation (MBF). 
In 2013, NICE published eight quality standards (NICEQS46) with the aim of 
improving the quality and consistency of clinical care for multiple pregnancy22.  Recent data 
from TAMBA evaluating uptake of these ‘key standards’, have indicated that there is still 
considerable variation in implementation by NHS healthcare providers across the UK23.  To 
provide objectivity to this claim, the TAMBA Maternity Engagement Project enrolled the 
participation of 30 maternity units across England to explore the range of uptake and 
adherence to the NICEQS46 standards during 2017.  The report attempted to look at 
hospital units based upon the perinatal services they provide and the number of total 
deliveries per annum. The King’s Fund estimates that there are approximately 150 maternity 
service providers in the UK, so a sample of 30 units is relatively small (˜20%) and therefore 
may have some representative selection bias.  However, these data were analysed using 
nested case-control methodology to explore the outcomes against a relative comparator 
within each group, and with a ‘control hospital’ designated within each of the designated 
complexity groups. This interim audit demonstrated a significant correlation between 
complete adherence to the NICEQS46 standards (thus implementation of guidance outlined 
in CG129) and improved clinical outcomes24. Furthermore, in the 29 centres audited, across 
hospital units of various size, obstetric and neonatal expertise and resourcing, there 
appeared to be a significant association between implementation of specific elements of the 
eight quality standards in NICEQS46 and lower stillbirth, neonatal admissions and neonatal 
deaths23,24. There is therefore some preliminary objective evidence that the NICE guidelines 
published in 2011, if implemented, may improve perinatal outcomes in twin pregnancies.  
Since 2011, the RCOG Green top Guidelines focusing specifically on monitoring and 
management of monochorionic twins have been updated18 with recommendations that 
complex monochorionic twins be referred for management by Fetal Medicine Specialists. 
International recommendations on the use of ultrasound in obstetric surveillance of twins has 
also been published21.  It is highly likely that these documents have further increased 
understanding surrounding the sophisticated and unique challenges that patients with 
multiple pregnancy face. 
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Although the recent data from MBRRACE relating to perinatal deaths in twin 
pregnancies is to be applauded there is no room for compliancy.  The variation in uptake and 
implementation in hospital centres across UK providers requires the universal development 
of multidisciplinary teams and clinics, which will require adequate resourcing and 
professional engagement.    
The risk of preterm birth is considerably higher, occurring in at least 50% of twin 
pregnancies25. Recent epidemiological data from the Netherlands of 51,658 twin 
pregnancies has noted that overall perinatal mortality rate was higher in twin pregnancies as 
compared to singletons.  The authors postulate that this is caused by high preterm birth rate 
and that in the preterm period (<37 weeks) the antenatal rate of stillbirth (after 28 weeks 
gestation) was lower than in singleton pregnancies, probably as a consequence of ‘closer 
monitoring’26. 
Although data indicate that the ultrasonographic measurement of cervical length 
between 18-24 weeks is a moderately good predictor of preterm birth in twins, attenuation of 
this risk has been hampered by a lack of evidence-based interventions19,20.    Data from an 
updated meta-analysis of individual patient data from several RCTs has demonstrated that 
vaginal progesterone administered to asymptomatic women with a twin gestation and a 
sonographically short cervix (<25mm) in the mid-trimester reduces both the risk of preterm 
birth (at < 30 to < 35 gestational weeks) and neonatal mortality27. In addition, ongoing 
research into potential therapies to attenuate the risk of preterm birth such as the use of the 
Arabin cervical pessary28 or targeted cervical cerclage may play a future role in further 
reducing perinatal mortality in twins as a consequence of preterm birth29. 
The timely identification of twins (particularly monochorionic twins) with selective 
growth restriction would allow assessment and the potential for in-utero management30,31.  
However, treatment strategies in the management of significant sGR in monochorionic twins 
(especially with abnormal fetoplacental Doppler assessment) are uncertain and range from 
conservative/expectant management with early, premature delivery, through the options of 
fetoscopic laser ablation of placental arteriovenous anastomoses or selective termination of 
pregnancy.  These choices are controversial and uncertain32,. They will form the basis of an 
evidence synthesis NIHR research call in the UK33, but there is some evidence that fetal 
therapy increases the risk overall of single twin demise (smaller twin). 
The regular ultrasound monitoring of monochorionic twin pregnancies for adverse 
pathologies such as TTTS has led to earlier and timely gestation of referral to centres with 
the expertise to manage these pregnancies by fetoscopic laser ablation18,34. The evaluation 
of screening in monochorionic twins to enhance detection may further improve this in the 
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future35.   However, despite improvement in technique (such as the SOLOMON technique 
reducing the risk of post-operative twin anaemia polycythaemia sequence) and outcomes36, 
the risk of preterm, premature ruptured membranes associated with the procedure increases 
the risk of miscarriage and preterm birth. The future pursuit of non-invasive techniques for 
treatment may further reduce miscarriage and perinatal loss associated with this disease37.   
It is also possible that earlier detection and diagnosis of TTTS38 leads to more timely, 
appropriate treatment that nonetheless, may be associated with single or indeed double twin 
demise before 24 weeks gestation (the threshold gestation at which the MBRRACE audit 
started to record fetal demise1), 
The recent MBRRACE data from the UK indicating a reduction in perinatal and 
neonatal death in twins is welcome, and documents a trend in reduced perinatal mortality 
associated with twin from the turn of this century.  The UK has been innovative in 
recommending the establishment of twin multidisciplinary teams and clinics, along with 
several national clinical guidelines to aid the management of twin and triplet pregnancies 
and high risk monochorionic pregnancies.  The introduction of and uptake clinically of these 
guidelines has almost certainly improved care reducing perinatal mortality rates in twins.  
However, universal adoption of these guidelines, with greater parent/healthcare worker 
interaction and prioritisation of research in areas of morbidity and mortality in twin pregnancy 
will further reduce pregnancy loss rates in these high-risk pregnancies39.      
A more comprehensive national assessment of the causes of perinatal mortality in 
twins by chorionicity would be very important and help to indicate the contribution of 
pathologies such as TTTS, TAPS, selective growth restriction and extreme preterm birth to 
fetal demise.  In August 2018, an MBRRACE Working Group was formed to ‘drill down’ and 
study a cohort of twin pregnancy stillbirths (>22 weeks) and neonatal deaths from a recently 
collected 2017 dataset to examine the relative contributions of national healthcare delivery 
and underlying aetiology. This will report in late 2019. 
Additionally, a UKOSS study has examined data from the UK in which there was 
single twin demise in monochorionic twin pregnancies between 2016-201740. There is a lack 
of robust data regarding the incidence of single twin demise; interventions offered; maternal, 
fetal and neonatal outcomes and any prognostic indicators. The knowledge gained from this 
study will enable recommendations for the management of monochorionic twin pregnancies 
following single twin demise and improve the counselling and management.  These two 
initiatives alongside the next MBRRACE-UK perinatal surveillance report from 2017-2018 
will by 2019 allow us to more robustly examine trends in changing rates of twin stillbirth and 
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early neonatal death in the UK and understand the contributing and possibly preventable 
causes. 
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Figure Legends 
 
FIGURE 1. 
Stillbirth rate in twins (per 1000 total births) from 2000-2016.  These data are from 
CMACE (orange), Scottish Perinatal Mortality data (Grey [no confidence limits 
reported) and the EMBRRACE data (Blue), published in 20181 
 
Figure 2. 
Crude figures from EMBRRACE-UK Report 20181: demonstrating the total number of 
twin deaths (stillbirths and neonatal deaths) between 2013-2016 as classified by 
chorionicity (monochorionic=MC; dichorionic=DC or unknown chorionicity=UKC). 
 
Figure 3.  
Change in twin stillbirth rates by chorionicity (where allocated) compared to singleton 
pregnancies1 
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95% confidence intervals where 
available are shown as error bars. 
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